Fig 3. pERK in resistant (stem-like) cell lines after treatment with MEK162 plus neratinib.
Protein profiling of stem-like cells lines (A) SW 480 and (B) C2BBE1 were performed as described in Fig 2.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.